INIT — Initiator Pharma A/S Income Statement
0.000.00%
Last trade - 00:00- SEK199.20m
- SEK160.35m
Annual income statement for Initiator Pharma A/S, fiscal year end - December 31st, DKK millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | Interim Report | ARS |
| Standards: | DAS | DAS | DAS | — | DAS |
| Status: | Final | Final | Final | Final | Final |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Selling / General / Administrative Expenses | |||||
| Depreciation and Amortization | |||||
| Other Operating Expenses | |||||
| Total Operating Expenses | 10.5 | 23.1 | 41.7 | 27 | 14.5 |
| Operating Profit | -10.5 | -23.1 | -41.7 | -27 | -14.5 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -10.2 | -24.2 | -44.1 | -27.7 | -14.8 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -8.7 | -21.1 | -38.5 | -27.7 | -12.9 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -8.7 | -21.1 | -38.5 | -27.7 | -12.9 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -8.7 | -21.1 | -38.5 | -27.7 | -12.9 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.296 | -0.481 | -0.796 | -0.529 | -0.232 |
| Dividends per Share |